Literature DB >> 21667613

Regional variation in electroconvulsive therapy use.

R Dunne1, D M McLoughlin.   

Abstract

Although electroconvulsive therapy (ECT) is the most powerful treatment for depression, substantial variability in use has been described in Ireland. The Mental Health Commission collects usage data from approved centres but does not include home addresses or independent sector patients. Therefore, estimates of regional variation cannot be accurate, e.g. 145 (35% of total) independent sector patients were omitted from their 2008 analysis. When public and independent sector patients are combined inter-regional variation for 2008 is more than halved (chi-squared decreased from 83 to 30), with Western region contributing most to variation (chi-squared = 43). Ratio of ECT programmes to depressed admissions correlated negatively with rate for depressed admissions (r = -0.53, p = 0.01), while depressed admission numbers correlated with acute beds per area (r = 0.68, p = 0.001). Regional variation in ECT is less than previously reported; service factors probably account for much of this with smaller centres admitting severely ill patients more likely to require ECT.

Entities:  

Mesh:

Year:  2011        PMID: 21667613

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  1 in total

1.  Ketamine for depression relapse prevention following electroconvulsive therapy: protocol for a randomised pilot trial (the KEEP-WELL trial).

Authors:  Martha Finnegan; Karen Ryan; Enda Shanahan; Andrew Harkin; Leslie Daly; Declan M McLoughlin
Journal:  Pilot Feasibility Stud       Date:  2016-08-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.